Gatehouse Bio, Inc. — Form D
Gatehouse Bio, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-15. The offering totals $5.4M, of which $5.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-01-15
- Form: D
- Accession: 0001840498-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.4M
- Amount sold: $5.4M
- Investors: 28
- Date of first sale: 2020-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-386501
Issuer
- Name: Gatehouse Bio, Inc.
- CIK: 0001840498
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 35 Gatehouse Drive, WALTHAM, MA, 02451
- Phone: (339) 707-7763
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Neal W Foster | Director | Waltham, MA |
| David W Salzman, Ph.D. | Director | Waltham, MA |
| Neal W Foster | Executive Officer | Waltham, MA |
| David W Salzman, Ph.D. | Executive Officer | Waltham, MA |
More